SCHEMBL15701567

SCHEMBL15701567

Cc1cc(C2CCN(C)CC2)c(=O)[nH]n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.42
HTR1F P30939 3/20 0.40
CALCRL Q16602 1/20 0.39
DRD4 P21917 1/20 0.39
MAPK11 Q15759 2/20 0.38
MAPK14 Q16539 2/20 0.38
PARP1 P09874 1/20 0.38
BRD4 O60885 1/20 0.37
ATAD2 Q6PL18 1/20 0.37
HTR1D P28221 3/20 0.37
HTR1B P28222 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
THPO P40225 1/20 0.37
HTR6 P50406 2/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2525898 0.81 HTR2C (0.42) PLGTLR9TLR8TLR7NOTUM
SCHEMBL17001894 0.73 HTR1F (0.47) PLGHTR1FHTR1DHTR1BCYP1A2
SCHEMBL30526339 0.73 SOS1 (0.38) PLGHTR1FDRD4PARP1HTR1D
Hydrochloric Acid SCHEMBL25307453 0.72 SOS1 (0.38) PLGHTR1FDRD4PARP1HTR1D
SCHEMBL13313599 0.66 HRH4 (0.49) HTR1FCALCRLPARP1BRD4CYP3A4
SCHEMBL14046566 0.66 OGA (0.49) PLGDRD4NOTUM
SCHEMBL17001657 0.66 HTR1F (0.49) PLGHTR1FHTR1DHTR1BCYP1A2
SCHEMBL30556420 0.65 HTR1F (0.41) PLGHTR1FPARP1BRD4ATAD2
SCHEMBL25280436 0.65 POLB (0.54) PARP1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1719925 0.64 HTR1D (0.50) HTR1FHTR1DHTR1BCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796260-B2 Imidazobenzazepine CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2014-08-05 US disclosed
US-20140128375-A1 BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. 2014-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140128375-A1 BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS BDKRB1, BDKRB2, CALCRL PLG 1335/4885HTR1F 133/4885CALCRL 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.